Zantac Lawsuits Cancer From NDMA Exposure

The U.S. Food and Drug Administration, along with European health agencies have warned that popular heartburn medication Zantac, and store-brand or other generic formulations of ranitidine, may contain a probable carcinogen, N-nitrosodimethylamine (NDMA).

Experts have suggested that while there may not be a high risk of cancer from long-term exposure to high levels of NDMA in Zantac and ranitidine medication, the risks for short-term exposure are low. 

However, it is possible to develop cancer from prolonged exposure. NDMA has been shown to be a carcinogen in industrial use. Individuals or their loved ones who have been diagnosed with cancer by Zantac (ranitidine), may be eligible to receive compensation. If you are also looking to file a lawsuit then you can get California Zantac cancer lawsuit FAQs from various online sources before moving ahead.

Zantac Lawsuits

Image Source: Google

These cancers may be linked to NDMA exposure:

  • Bladder cancer
  • Testicular
  • Kidney cancer
  • Breast cancer
  • Prostate cancer

Past cases involving drug injuries have resulted in damages including:

  • Medical expenses
  • Lost Local Workers
  • The two most painful things in life are suffering and pain
  • Disability
  • Punitive damages
  • Wrongful deaths

In the nutshell, the U.S. Environmental Protection Agency, (EPA) states that NDMA can sometimes be found in food and water. It is an organic compound that acts as a chemical stabilizer in gasoline, diesel fuel, rocket fuel, and other petroleum-based products.